BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 239 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $113,284 | +688.0% | 22,300 | +829.2% | 0.01% | +500.0% |
| Q4 2023 | $14,376 | -96.8% | 2,400 | -96.3% | 0.00% | -96.7% |
| Q3 2023 | $453,828 | +229.8% | 64,100 | +288.5% | 0.03% | +200.0% |
| Q1 2023 | $137,610 | -80.8% | 16,500 | -66.9% | 0.01% | -80.8% |
| Q3 2021 | $715,000 | +2066.7% | 49,800 | +2271.4% | 0.05% | +1633.3% |
| Q2 2021 | $33,000 | -79.5% | 2,100 | -86.8% | 0.00% | -80.0% |
| Q1 2021 | $161,000 | +403.1% | 15,900 | +69.1% | 0.02% | +275.0% |
| Q3 2020 | $32,000 | -68.0% | 9,400 | +39.1% | 0.00% | -77.8% |
| Q2 2015 | $100,000 | +85.2% | 6,759 | +22.3% | 0.02% | +157.1% |
| Q3 2014 | $54,000 | +440.0% | 5,527 | +452.7% | 0.01% | +250.0% |
| Q1 2014 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |